# Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

> **NCT01339052** · PHASE2 · COMPLETED · sponsor: **Patrick Y. Wen, MD** · enrollment: 65 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** BKM120
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01339052
- **Lead sponsor:** Patrick Y. Wen, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2016-10
- **Final completion:** 2019-02
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2019-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339052, "Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01339052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*